Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364740 · ClinicalTrials.gov registry record · Phase 3
PMP-300E (Smart Watch): Portable Monitoring Device Study
A Phase 3 study of Obstructive Sleep Apnea, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT01364740: Completed Phase 3 study of Obstructive Sleep Apnea, sponsored by Stanford University.
NCT01364740 is a Phase 3 study of Obstructive Sleep Apnea that has completed, run by Stanford University. The registered enrollment target is 10 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01364740, a Phase 3 study of Obstructive Sleep Apnea, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
Primary Outcome
Apnea-Hypopnea Index (number of events/hour of sleep). Hypopneas scored without EEG arousals.
Conditions Studied
Interventions
- DEVICE PMP-300E
- DEVICE In-lab PSG
Study Locations (2)
California
- Center for Human Sleep Research - Redwood City
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT01364740 record still lists
NCT01364740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which PMP-300E is the first listed.
NCT01364740 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01364740 about?
NCT01364740 is a clinical study titled "PMP-300E (Smart Watch): Portable Monitoring Device Study". Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
What is the current status of trial NCT01364740?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2008-06. Estimated completion is 2012-06.
What conditions does trial NCT01364740 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01364740?
The interventions under investigation include: PMP-300E (DEVICE), In-lab PSG (DEVICE).
Who is sponsoring clinical trial NCT01364740?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01364740 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01364740's enrollment target sits among peer trials
10 152nd of 155 higher than 2 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
RECRUITING · Phase 3
-
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
ACTIVE NOT RECRUITING · Phase 3
-
Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia